Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Suzette Girgis"'
Autor:
Ajai Chari, Monique C. Minnema, Jesus G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano J. Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B. Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W. Hilder, Jeffery Russell, Jenna D. Goldberg, Amrita Krishnan
Publikováno v:
Chari, A, Minnema, M C, Berdeja, J G, Oriol, A, van de Donk, N W C J, Rodríguez-Otero, P, Askari, E, Mateos, M-V, Costa, L J, Caers, J, Verona, R, Girgis, S, Yang, S, Goldsmith, R B, Yao, X, Pillarisetti, K, Hilder, B W, Russell, J, Goldberg, J D & Krishnan, A 2022, ' Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma ', The New England journal of medicine, vol. 387, no. 24, pp. 2232-2244 . https://doi.org/10.1056/NEJMoa2204591
The New England journal of medicine, 387(24), 2232-2244. Massachussetts Medical Society
The New England journal of medicine, 387(24), 2232-2244. Massachussetts Medical Society
BACKGROUND: G protein-coupled receptor, family C, group 5, member D (GPRC5D) is an orphan receptor expressed in malignant plasma cells. Talquetamab, a bispecific antibody against CD3 and GPRC5D, redirects T cells to mediate killing of GPRC5D-expressi
Autor:
Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San-Miguel, Albert Oriol, Ajay K. Nooka, Thomas Martin, Laura Rosinol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, Maria-Victoria Mateos, Nizar Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez-López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Shun X.W. Lin, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan, Saad Z. Usmani
Publikováno v:
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Moreau, P, Garfall, A L, van de Donk, N W C J, Nahi, H, San-Miguel, J F, Oriol, A, Nooka, A K, Martin, T, Rosinol, L, Chari, A, Karlin, L, Benboubker, L, Mateos, M-V, Bahlis, N, Popat, R, Besemer, B, Martínez-López, J, Sidana, S, Delforge, M, Pei, L, Trancucci, D, Verona, R, Girgis, S, Lin, S X W, Olyslager, Y, Jaffe, M, Uhlar, C, Stephenson, T, van Rampelbergh, R, Banerjee, A, Goldberg, J D, Kobos, R, Krishnan, A & Usmani, S Z 2022, ' Teclistamab in Relapsed or Refractory Multiple Myeloma ', New England Journal of Medicine, vol. 387, no. 6, pp. 495-505 . https://doi.org/10.1056/NEJMoa2203478
New England Journal of Medicine, 387(6), 495-505. Massachussetts Medical Society
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Moreau, P, Garfall, A L, van de Donk, N W C J, Nahi, H, San-Miguel, J F, Oriol, A, Nooka, A K, Martin, T, Rosinol, L, Chari, A, Karlin, L, Benboubker, L, Mateos, M-V, Bahlis, N, Popat, R, Besemer, B, Martínez-López, J, Sidana, S, Delforge, M, Pei, L, Trancucci, D, Verona, R, Girgis, S, Lin, S X W, Olyslager, Y, Jaffe, M, Uhlar, C, Stephenson, T, van Rampelbergh, R, Banerjee, A, Goldberg, J D, Kobos, R, Krishnan, A & Usmani, S Z 2022, ' Teclistamab in Relapsed or Refractory Multiple Myeloma ', New England Journal of Medicine, vol. 387, no. 6, pp. 495-505 . https://doi.org/10.1056/NEJMoa2203478
New England Journal of Medicine, 387(6), 495-505. Massachussetts Medical Society
BACKGROUND Teclistamab is a T-cell-redirecting bispecific antibody that targets both CD3 expressed on the surface of T cells and B-cell maturation antigen expressed on the surface of myeloma cells. In the phase 1 dose-defining portion of the study, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae6351ce203c3722facd40c1ebcc5de
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7233
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7233